PMC:7102662 / 14765-18861
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T39 | 1435-1443 | Body_part | denotes | troponin | http://purl.org/sig/ont/fma/fma62338 |
| T40 | 1844-1853 | Body_part | denotes | troponins | http://purl.org/sig/ont/fma/fma62338 |
| T41 | 2609-2616 | Body_part | denotes | tissues | http://purl.org/sig/ont/fma/fma9637 |
| T42 | 2631-2645 | Body_part | denotes | cardiomyocytes | http://purl.org/sig/ont/fma/fma14067 |
| T43 | 2708-2713 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T144 | 63-71 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T145 | 172-180 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T146 | 430-438 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T147 | 733-741 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T148 | 892-900 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T149 | 1281-1289 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T150 | 1711-1720 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T151 | 2040-2048 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T152 | 2333-2341 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T153 | 2359-2401 | Disease | denotes | ST-segment elevation myocardial infarction | http://purl.obolibrary.org/obo/MONDO_0041656 |
| T154 | 2380-2401 | Disease | denotes | myocardial infarction | http://purl.obolibrary.org/obo/MONDO_0005068 |
| T155 | 2512-2515 | Disease | denotes | ARB | http://purl.obolibrary.org/obo/MONDO_0012733 |
| T156 | 2536-2544 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T157 | 2658-2666 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T158 | 2767-2775 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T159 | 2872-2875 | Disease | denotes | ARB | http://purl.obolibrary.org/obo/MONDO_0012733 |
| T160 | 3160-3163 | Disease | denotes | ARB | http://purl.obolibrary.org/obo/MONDO_0012733 |
| T161 | 3206-3214 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T162 | 3368-3383 | Disease | denotes | viral infection | http://purl.obolibrary.org/obo/MONDO_0005108 |
| T163 | 3374-3383 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T95 | 201-202 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T96 | 527-537 | http://purl.obolibrary.org/obo/CLO_0002807 | denotes | in donning |
| T97 | 1415-1420 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
| T98 | 1757-1760 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T99 | 1870-1878 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptides |
| T100 | 2091-2094 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T101 | 2107-2108 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T102 | 2359-2361 | http://purl.obolibrary.org/obo/CLO_0009141 | denotes | ST |
| T103 | 2359-2361 | http://purl.obolibrary.org/obo/CLO_0050980 | denotes | ST |
| T104 | 2412-2415 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T105 | 2421-2422 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T106 | 2631-2645 | http://purl.obolibrary.org/obo/CL_0000746 | denotes | cardiomyocytes |
| T107 | 2702-2713 | http://purl.obolibrary.org/obo/CLO_0053065 | denotes | human cells |
| T108 | 2724-2725 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T22 | 1870-1878 | Chemical | denotes | peptides | http://purl.obolibrary.org/obo/CHEBI_16670 |
| T23 | 2359-2361 | Chemical | denotes | ST | http://purl.obolibrary.org/obo/CHEBI_141393 |
| T24 | 2455-2469 | Chemical | denotes | ACE inhibitors | http://purl.obolibrary.org/obo/CHEBI_35457 |
| T25 | 2459-2469 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T26 | 2471-2475 | Chemical | denotes | ACEi | http://purl.obolibrary.org/obo/CHEBI_35457 |
| T27 | 2481-2492 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
| T28 | 2867-2871 | Chemical | denotes | ACEi | http://purl.obolibrary.org/obo/CHEBI_35457 |
| T29 | 3155-3159 | Chemical | denotes | ACEi | http://purl.obolibrary.org/obo/CHEBI_35457 |
| T30 | 3423-3428 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T31 | 3472-3477 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T32 | 3562-3573 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T33 | 3574-3592 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
| T34 | 3597-3609 | Chemical | denotes | azathioprine | http://purl.obolibrary.org/obo/CHEBI_2948 |
| T35 | 3710-3715 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T36 | 3868-3879 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T37 | 3880-3898 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
| T38 | 4053-4057 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T45 | 2359-2379 | Phenotype | denotes | ST-segment elevation | http://purl.obolibrary.org/obo/HP_0012251 |
| T46 | 2380-2401 | Phenotype | denotes | myocardial infarction | http://purl.obolibrary.org/obo/HP_0001658 |
| T47 | 3729-3748 | Phenotype | denotes | prolong QT interval | http://purl.obolibrary.org/obo/HP_0001657 |
| T48 | 4076-4095 | Phenotype | denotes | prolong QT interval | http://purl.obolibrary.org/obo/HP_0001657 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T22 | 2303-2315 | http://purl.obolibrary.org/obo/GO_0042730 | denotes | fibrinolysis |
| T23 | 3368-3383 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infection |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T122 | 0-181 | Sentence | denotes | The overall management principles for patients presenting with COVID-19 who develop CV complications or who have pre-existing CVD are same as for any other patient without COVID-19. |
| T123 | 182-250 | Sentence | denotes | However, there are a few important points that need consideration-1. |
| T124 | 251-371 | Sentence | denotes | As caregivers, it is our utmost responsibility to protect ourselves from getting infected while managing these patients. |
| T125 | 372-496 | Sentence | denotes | Therefore, all heathcare personnel engaged in the care of COVID-19 patients must observe necessary precautions at all times. |
| T126 | 497-647 | Sentence | denotes | All of them should be trained in donning, usage, and doffing of the personal protective equipment in accordance with the existing practice guidelines. |
| T127 | 648-650 | Sentence | denotes | 2. |
| T128 | 651-811 | Sentence | denotes | The hospital systems need to ensure preparedness for dealing with large volume of COVID-19 patients, many of whom would need ICU care and/or acute cardiac care. |
| T129 | 812-971 | Sentence | denotes | Appropriate protocols for rapid diagnosis, triage, isolation, and management of COVID-19 patients with CV complications should be developed and well-rehearsed. |
| T130 | 972-1140 | Sentence | denotes | Rapid triaging and management of these patients is crucial, not only to allow efficient utilization of healthcare resources but also to minimize exposure to caregivers. |
| T131 | 1141-1295 | Sentence | denotes | There are already reports highlighting delays in delivering acute cardiac care due to extra precautions that need to be observed in view of COVID-19 [14]. |
| T132 | 1296-1343 | Sentence | denotes | Efforts should be made to minimize such delays. |
| T133 | 1344-1346 | Sentence | denotes | 3. |
| T134 | 1347-1487 | Sentence | denotes | Strong emphasis should be placed on avoiding unwarranted diagnostic tests (e.g. cardiac troponin, echocardiography, etc.) in these patients. |
| T135 | 1488-1721 | Sentence | denotes | This is required to minimize unwarranted downstream diagnostic/therapeutic procedures which would further strain the already stretched healthcare resources and would also subject caregivers to added risk of exposure to the infection. |
| T136 | 1722-1884 | Sentence | denotes | The American College of Cardiology has released an advisory discouraging random measurement of cardiac biomarkers such as troponins and natriuretic peptides [15]. |
| T137 | 1885-2049 | Sentence | denotes | It urges all the clinicians to reserve these assays for circumstances in which they would actually meaningfully add to the management of the patients with COVID-19. |
| T138 | 2050-2187 | Sentence | denotes | The American Society of Echocardiography has also issued a similar advisory regarding the use of echocardiography in these patients [16]. |
| T139 | 2188-2190 | Sentence | denotes | 4. |
| T140 | 2191-2402 | Sentence | denotes | The individual hospitals may also have to reconsider risk-benefit ratio of primary percutaneous intervention vs fibrinolysis in patients with COVID-19 who present with ST-segment elevation myocardial infarction. |
| T141 | 2403-2405 | Sentence | denotes | 5. |
| T142 | 2406-2554 | Sentence | denotes | There has been a concern regarding the safety of ACE inhibitors (ACEi) and angiotensin receptor blockers (ARB) during the ongoing COVID-19 pandemic. |
| T143 | 2555-2651 | Sentence | denotes | These agents upregulate expression of ACE2 in various tissues, including on cardiomyocytes [17]. |
| T144 | 2652-2876 | Sentence | denotes | Since SARS-CoV-2 binds to ACE2 to gain entry into human cells, there is a potentially increased risk of developing COVID-19 or developing more severe disease in patients who are already on background treatment with ACEi/ARB. |
| T145 | 2877-2967 | Sentence | denotes | However, to date, no experimental or clinical data have emerged to support these concerns. |
| T146 | 2968-3044 | Sentence | denotes | At the same time, the risks of discontinuing these therapies are well known. |
| T147 | 3045-3223 | Sentence | denotes | Therefore, several leading professional societies have strongly urged to not discontinue clinically-indicated ACEi/ARB therapy in the event the patient develops COVID-19 [18,19]. |
| T148 | 3224-3226 | Sentence | denotes | 6. |
| T149 | 3227-3384 | Sentence | denotes | Clinicians caring for these patients also need to be fully aware of the potential CV side-effects of various therapies used for treating the viral infection. |
| T150 | 3385-3546 | Sentence | denotes | Additionally, various anti-retroviral drugs have significant interactions with cardiac drugs, which need to be considered and appropriate dose modification done. |
| T151 | 3547-3698 | Sentence | denotes | More recently, chloroquine/hydroxychloroquine and azathioprine have been proposed as potential therapeutic options, based on preliminary evidence [20]. |
| T152 | 3699-3813 | Sentence | denotes | Both these drugs are known to prolong QT interval and due caution must be exercised when prescribing these agents. |
| T153 | 3814-4096 | Sentence | denotes | Their combination is best avoided and even when using chloroquine/hydroxychloroquine alone, daily electrocardiogram for monitoring QT interval is warranted, esp. in patients with hepatic or renal dysfunction and in those receiving another drug with potential to prolong QT interval. |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T258 | 63-71 | SP_7 | denotes | COVID-19 |
| T259 | 172-180 | SP_7 | denotes | COVID-19 |
| T260 | 430-438 | SP_7 | denotes | COVID-19 |
| T261 | 733-741 | SP_7 | denotes | COVID-19 |
| T262 | 798-805 | UBERON:0000948 | denotes | cardiac |
| T263 | 892-900 | SP_7 | denotes | COVID-19 |
| T264 | 1190-1200 | GO:0007567 | denotes | delivering |
| T265 | 1207-1214 | UBERON:0000948 | denotes | cardiac |
| T266 | 1281-1289 | SP_7 | denotes | COVID-19 |
| T267 | 1427-1434 | UBERON:0000948 | denotes | cardiac |
| T268 | 1746-1756 | UBERON:0000948 | denotes | Cardiology |
| T269 | 1817-1824 | UBERON:0000948 | denotes | cardiac |
| T270 | 2040-2048 | SP_7 | denotes | COVID-19 |
| T271 | 2303-2315 | GO:0042730 | denotes | fibrinolysis |
| T272 | 2333-2341 | SP_7 | denotes | COVID-19 |
| T273 | 2380-2390 | UBERON:0002349 | denotes | myocardial |
| T274 | 2459-2469 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
| T275 | 2493-2510 | CHEBI:48561;CHEBI:48561 | denotes | receptor blockers |
| T276 | 2536-2544 | SP_7 | denotes | COVID-19 |
| T277 | 2579-2589 | GO:0010467 | denotes | expression |
| T278 | 2593-2597 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
| T279 | 2609-2616 | UBERON:0000479 | denotes | tissues |
| T280 | 2631-2645 | CL:0000746 | denotes | cardiomyocytes |
| T281 | 2658-2668 | SP_7 | denotes | SARS-CoV-2 |
| T282 | 2678-2682 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
| T283 | 2702-2707 | SP_6;NCBITaxon:9606 | denotes | human |
| T284 | 2767-2775 | SP_7 | denotes | COVID-19 |
| T285 | 3206-3214 | SP_7 | denotes | COVID-19 |
| T286 | 3368-3373 | NCBITaxon:10239 | denotes | viral |
| T287 | 3407-3412 | CHEBI:67079;CHEBI:67079 | denotes | anti- |
| T288 | 3412-3422 | NCBITaxon:11632 | denotes | retroviral |
| T289 | 3423-3428 | CHEBI:23888;CHEBI:23888 | denotes | drugs |
| T290 | 3464-3471 | UBERON:0000948 | denotes | cardiac |
| T291 | 3472-3477 | CHEBI:23888;CHEBI:23888 | denotes | drugs |
| T292 | 3562-3573 | CHEBI:3638;DG_10;CHEBI:3638 | denotes | chloroquine |
| T293 | 3574-3592 | CHEBI:5801;DG_20;CHEBI:5801 | denotes | hydroxychloroquine |
| T294 | 3597-3609 | CHEBI:2948;CHEBI:2948 | denotes | azathioprine |
| T295 | 3710-3715 | CHEBI:23888;CHEBI:23888 | denotes | drugs |
| T296 | 3806-3812 | CHEBI:23888;CHEBI:23888 | denotes | agents |
| T297 | 3868-3879 | CHEBI:3638;DG_10;CHEBI:3638 | denotes | chloroquine |
| T298 | 3880-3898 | CHEBI:5801;DG_20;CHEBI:5801 | denotes | hydroxychloroquine |
| T299 | 3993-4000 | UBERON:0002107 | denotes | hepatic |
| T300 | 4004-4009 | UBERON:0002113 | denotes | renal |
| T301 | 4053-4057 | CHEBI:23888;CHEBI:23888 | denotes | drug |
| T44699 | 212-217 | UBERON:0000948 | denotes | tant |
| T13321 | 242-249 | UBERON:0000948 | denotes | ation-1 |
| T1958 | 308-312 | GO:0016265 | denotes | our |
| T10093 | 387-393 | GO:0016265 | denotes | heathc |
| T26141 | 557-571 | UBERON:0004535 | denotes | of the person |
| T57516 | 590-598 | SP_7 | denotes | ment in |
| T16826 | 611-622 | UBERON:0002349 | denotes | th the exis |
| T31833 | 636-646 | UBERON:0002349 | denotes | guidelines |
| T58582 | 705-713 | SP_7 | denotes | ealing w |
| T94661 | 785-795 | UBERON:0002349 | denotes | and/or acu |
| T87705 | 822-829 | UBERON:0000948 | denotes | e proto |
| T48656 | 958-965 | UBERON:0000948 | denotes | ll-rehe |
| T7641 | 1105-1112 | UBERON:0000948 | denotes | to mini |
| T19884 | 1322-1329 | UBERON:0000948 | denotes | minimiz |
| T28710 | 1421-1426 | GO:0016265 | denotes | (e.g. |
| T28698 | 1542-1549 | UBERON:0000948 | denotes | agnosti |
| T59720 | 1644-1652 | SP_7 | denotes | and woul |
| T39589 | 1976-1983 | UBERON:0000948 | denotes | ctually |
| T43336 | 2003-2010 | UBERON:0000948 | denotes | the ma |
| T74507 | 2038-2046 | SP_7 | denotes | h COVID- |
| T87124 | 2140-2148 | UBERON:0001621 | denotes | use of e |
| T70670 | 2150-2160 | UBERON:0002349 | denotes | ocardiogra |
| T13529 | 2175-2180 | NCBITaxon:10239 | denotes | tient |
| T86273 | 2355-2359 | GO:0016265 | denotes | ith |
| T62094 | 2367-2371 | SP_10 | denotes | nt e |
| T86471 | 2391-2395 | SP_10 | denotes | infa |
| T29868 | 2430-2435 | NCBITaxon:10239 | denotes | rega |
| T44693 | 2487-2492 | SP_6;NCBITaxon:9606 | denotes | ensin |
| T30153 | 2493-2498 | UBERON:0000948 | denotes | recep |
| T84285 | 2538-2548 | UBERON:0002349 | denotes | VID-19 pan |
| T53976 | 2563-2568 | NCBITaxon:10239 | denotes | ents |
| T87440 | 2631-2641 | UBERON:0002349 | denotes | cardiomyoc |
| T16635 | 2656-2664 | SP_7 | denotes | e SARS-C |
| T1147 | 2720-2736 | UBERON:0002084 | denotes | is a potentiall |
| T55144 | 2766-2782 | UBERON:0002084 | denotes | COVID-19 or dev |
| T79081 | 2887-2892 | UBERON:0000948 | denotes | o dat |
| T98834 | 2904-2912 | SP_7 | denotes | mental o |
| T81730 | 2927-2932 | UBERON:0000948 | denotes | have |
| T81536 | 2994-2998 | GO:0016265 | denotes | s of |
| T85605 | 3141-3149 | SP_7 | denotes | lly-indi |
| T35536 | 3227-3235 | SP_7 | denotes | Clinicia |
| T14057 | 3489-3497 | SP_7 | denotes | to be c |
| T37740 | 3652-3660 | CHEBI:33695;CHEBI:33695;SO:0000673 | denotes | c option |
| T78714 | 3707-3711 | SP_10 | denotes | se d |
| T37413 | 3723-3731 | SP_10 | denotes | wn to pr |
| T33567 | 3775-3785 | SP_7 | denotes | ercised wh |
| T76508 | 3846-3850 | SP_10 | denotes | d an |
| T48944 | 3890-3894 | CHEBI:18059;CHEBI:18059;GO:0006629 | denotes | oroq |
| T57411 | 3895-3903 | GO:0006629 | denotes | ine alon |
| T94539 | 3976-3983 | CHEBI:17234;CHEBI:17234;GO:0006006 | denotes | in pati |
| T59989 | 3984-3992 | GO:0006006 | denotes | nts with |
| T68492 | 18-29 | CHEBI:3638;DG_10;CHEBI:3638 | denotes | ment princi |
| T72351 | 30-48 | CHEBI:5801;DG_20;CHEBI:5801 | denotes | les for patients p |
| T96108 | 144-151 | UBERON:0002107 | denotes | r any o |
| T69138 | 155-160 | UBERON:0002113 | denotes | pati |
| T30274 | 204-208 | CHEBI:23888;CHEBI:23888 | denotes | ew i |
| T302 | 430-438 | SP_7 | denotes | COVID-19 |
| T303 | 733-741 | SP_7 | denotes | COVID-19 |
| T304 | 798-805 | UBERON:0000948 | denotes | cardiac |
| T305 | 892-900 | SP_7 | denotes | COVID-19 |
| T306 | 1190-1200 | GO:0007567 | denotes | delivering |
| T307 | 1207-1214 | UBERON:0000948 | denotes | cardiac |
| T308 | 1281-1289 | SP_7 | denotes | COVID-19 |
| T309 | 1427-1434 | UBERON:0000948 | denotes | cardiac |
| T310 | 1746-1756 | UBERON:0000948 | denotes | Cardiology |
| T311 | 1817-1824 | UBERON:0000948 | denotes | cardiac |
| T312 | 2040-2048 | SP_7 | denotes | COVID-19 |
| T313 | 2303-2315 | GO:0042730 | denotes | fibrinolysis |
| T314 | 2333-2341 | SP_7 | denotes | COVID-19 |
| T315 | 2380-2390 | UBERON:0002349 | denotes | myocardial |
| T316 | 2459-2469 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
| T317 | 2493-2510 | CHEBI:48561;CHEBI:48561 | denotes | receptor blockers |
| T318 | 2536-2544 | SP_7 | denotes | COVID-19 |
| T319 | 2579-2589 | GO:0010467 | denotes | expression |
| T320 | 2593-2597 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
| T321 | 2609-2616 | UBERON:0000479 | denotes | tissues |
| T322 | 2631-2645 | CL:0000746 | denotes | cardiomyocytes |
| T323 | 2658-2668 | SP_7 | denotes | SARS-CoV-2 |
| T324 | 2678-2682 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
| T325 | 2702-2707 | SP_6;NCBITaxon:9606 | denotes | human |
| T326 | 2767-2775 | SP_7 | denotes | COVID-19 |
| T327 | 3206-3214 | SP_7 | denotes | COVID-19 |
| T328 | 3368-3373 | NCBITaxon:10239 | denotes | viral |
| T329 | 3407-3412 | CHEBI:67079;CHEBI:67079 | denotes | anti- |
| T330 | 3412-3422 | NCBITaxon:11632 | denotes | retroviral |
| T331 | 3423-3428 | CHEBI:23888;CHEBI:23888 | denotes | drugs |
| T332 | 3464-3471 | UBERON:0000948 | denotes | cardiac |
| T333 | 3472-3477 | CHEBI:23888;CHEBI:23888 | denotes | drugs |
| T334 | 3562-3573 | CHEBI:3638;DG_10;CHEBI:3638 | denotes | chloroquine |
| T335 | 3574-3592 | CHEBI:5801;DG_20;CHEBI:5801 | denotes | hydroxychloroquine |
| T336 | 3597-3609 | CHEBI:2948;CHEBI:2948 | denotes | azathioprine |
| T337 | 3710-3715 | CHEBI:23888;CHEBI:23888 | denotes | drugs |
| T338 | 3806-3812 | CHEBI:23888;CHEBI:23888 | denotes | agents |
| T339 | 3868-3879 | CHEBI:3638;DG_10;CHEBI:3638 | denotes | chloroquine |
| T340 | 3880-3898 | CHEBI:5801;DG_20;CHEBI:5801 | denotes | hydroxychloroquine |
| T341 | 3993-4000 | UBERON:0002107 | denotes | hepatic |
| T342 | 4004-4009 | UBERON:0002113 | denotes | renal |
| T343 | 4053-4057 | CHEBI:23888;CHEBI:23888 | denotes | drug |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32247212-15897343-25241183 | 2647-2649 | 15897343 | denotes | 17 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 456 | 362-370 | Species | denotes | patients | Tax:9606 |
| 457 | 439-447 | Species | denotes | patients | Tax:9606 |
| 458 | 332-340 | Disease | denotes | infected | MESH:D007239 |
| 459 | 430-438 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 466 | 742-750 | Species | denotes | patients | Tax:9606 |
| 467 | 901-909 | Species | denotes | patients | Tax:9606 |
| 468 | 1011-1019 | Species | denotes | patients | Tax:9606 |
| 469 | 733-741 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 470 | 892-900 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 471 | 1281-1289 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 477 | 1478-1486 | Species | denotes | patients | Tax:9606 |
| 478 | 2026-2034 | Species | denotes | patients | Tax:9606 |
| 479 | 2173-2181 | Species | denotes | patients | Tax:9606 |
| 480 | 1711-1720 | Disease | denotes | infection | MESH:D007239 |
| 481 | 2040-2048 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 485 | 2319-2327 | Species | denotes | patients | Tax:9606 |
| 486 | 2333-2341 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 487 | 2380-2401 | Disease | denotes | myocardial infarction | MESH:D009203 |
| 498 | 2455-2458 | Gene | denotes | ACE | Gene:1636 |
| 499 | 2593-2597 | Gene | denotes | ACE2 | Gene:59272 |
| 500 | 2678-2682 | Gene | denotes | ACE2 | Gene:59272 |
| 501 | 2658-2668 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 502 | 2702-2707 | Species | denotes | human | Tax:9606 |
| 503 | 2813-2821 | Species | denotes | patients | Tax:9606 |
| 504 | 3189-3196 | Species | denotes | patient | Tax:9606 |
| 505 | 2536-2544 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 506 | 2767-2775 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 507 | 3206-3214 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 518 | 3971-3974 | Gene | denotes | esp | Gene:148713 |
| 519 | 3255-3263 | Species | denotes | patients | Tax:9606 |
| 520 | 3979-3987 | Species | denotes | patients | Tax:9606 |
| 521 | 3562-3573 | Chemical | denotes | chloroquine | MESH:D002738 |
| 522 | 3574-3592 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
| 523 | 3597-3609 | Chemical | denotes | azathioprine | MESH:D001379 |
| 524 | 3868-3879 | Chemical | denotes | chloroquine | MESH:D002738 |
| 525 | 3880-3898 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
| 526 | 3368-3383 | Disease | denotes | viral infection | MESH:D001102 |
| 527 | 3993-4021 | Disease | denotes | hepatic or renal dysfunction | MESH:D008107 |
| 533 | 38-46 | Species | denotes | patients | Tax:9606 |
| 534 | 156-163 | Species | denotes | patient | Tax:9606 |
| 535 | 63-71 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 536 | 126-129 | Disease | denotes | CVD | MESH:D002318 |
| 537 | 172-180 | Disease | denotes | COVID-19 | MESH:C000657245 |